With its dual role, apoB is therefore involved in hypercholesterolemia in cases of LDLR-binding defects (MIM: 144,010) [7,8] and in FHBL1 in cases of apoB secretion defects. This evidence concerns the gene APOB and familial hypercholesterolemia.